当前位置: 首页 > 详情页

The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, The Second Affiliated Hospital of Suzhou University, Suzhou 215004, China [2]Neuroscient PET Laboratory, Mt. Sinai School of Medicine, New York, NY 10029, USA [3]Beijing University of Technology, Beijing 100022, China
出处:
ISSN:

关键词: Cerebral infarction Platelet-leukocyte aggregations Aspirin Clopidogrel

摘要:
Background Studies have shown that platelet-leukocyte aggregates (PLA) are sensitive to platelet activation which might exist before the onset of cerebral infarction. In this study, we investigated the formation of PLA in patients with cerebral infarction and the effects of antiplatelet agents on PLA. Methods The level of soluble P-selectin, C-reaction protein, platelet aggregation rate and leukocyte-platelet aggregations were measured in 40 patients with acute cerebral infarction and 20 normal controls. The 40 patients were randomly assigned to two treatment groups: aspirin group (n = 20) and clopidogrel group (n = 20). Both groups were monitored for Scandinavian stroke scale (SNSS), soluble P-selectin, serum C-reaction protein, platelet aggregation rate and PLA before and after the treatment. Flow cytometry was used to detect the levels of PLA in the blood. Results The percentage of platelet-monocyte aggregates (PMA) in patients with cerebral infarction was significantly increased compared with the controls (P < 0.001), which was positively correlated to soluble P-selectin, C-reaction protein and platelet aggregation rate (P < 0.05). After the treatment, the levels of PMA and platelet aggregation rate were decreased in both groups (P < 0.05). The level of PMA and platelet aggregation rate in the clopidogrel group was significantly lower than that in the aspirin group (P < 0.05). Conclusions PMA are a sensitive biomarker to platelet activation in patients with cerebral infarction. In addition, although both aspirin and clopidogrel lowered the level of PMA, clopidogrel is a more effective treatment than aspirin in inhibiting platelet activation.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2008]版:
大类 | 4 区 医学
小类 | 4 区 血液学 4 区 外周血管病
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 血液学 4 区 心脏和心血管系统 4 区 外周血管病
JCR分区:
出版当年[2007]版:
Q3 PERIPHERAL VASCULAR DISEASE Q3 HEMATOLOGY
最新[2023]版:
Q2 HEMATOLOGY Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Q2 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2007版] 出版当年五年平均 出版前一年[2006版] 出版后一年[2008版]

第一作者:
第一作者机构: [1]Department of Neurology, The Second Affiliated Hospital of Suzhou University, Suzhou 215004, China
通讯作者:
通讯机构: [1]Department of Neurology, The Second Affiliated Hospital of Suzhou University, Suzhou 215004, China [3]Beijing University of Technology, Beijing 100022, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16399 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院